MCI Screen

Uses your system voice; voice and rate in settings.

Q6714915Snapshot

≈ 2 min read

Names in other languages

  • EnglishMCI Screen

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

The MCI Screen is a brief neuropsychological test checking for mild cognitive impairment (MCI). The protocol consists of an immediate recall task, a triadic comparison task, a judgment task, a delayed free recall task, a cued-recall task, and a rehearsed recall task. It is scored using correspondence analysis and statistical methods for differentiating normal cognitive function from Mild cognitive impairment. The methodology for scoring the MCI Screen was developed by the Embic Corporation (formerly Medical Care Corporation), a privately held California Corporation. It was derived from the protocol of the CERAD 10-word recall test.

The MCI Screen is a brief neuropsychological test checking for mild cognitive impairment (MCI). The protocol consists of an immediate recall task, a triadic comparison task, a judgment task, a delayed free recall task, a cued-recall task, and a rehearsed recall task. It is scored using correspondence analysis and statistical methods for differentiating normal cognitive function from Mild cognitive impairment. The methodology for scoring the MCI Screen was developed by the Embic Corporation (formerly Medical Care Corporation), a privately held California Corporation. It was derived from the protocol of the CERAD 10-word recall test.

Validation

The MCI Screen was validated in a study on 471 community-dwelling adults whose scores on the Clinical Dementia Rating Scale ranged from 0 (normal: N=119), 0.5 (mild cognitive impairment: N=95), to 1 (mild dementia: N=257). According to a 2005 publication in The Proceedings of the National Academy of Sciences, the MCI Screen has overall accuracy of 98% with sensitivity of 97% for mild cognitive impairment or mild dementia, and 88% specificity for normal aging. Clinical studies in the USA have shown that the MCI Screen detects early-stage memory loss due to multiple underlying medical conditions including Alzheimer's disease and cerebrovascular disease. Japan-based studies have demonstrated cross-cultural validity of the MCI Screen in clinical and academic settings with accuracy levels equal to those in the USA.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374591800 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.